|
|||||
|
|||||
|
Speakers
|
|||||
|
About Stellar Pharmaceuticals Stellar has developed and is marketing direct in Canada, and in countries around the world through out-license agreements, three products based on its core polysaccharide technology: NeoVisc®, for the treatment of osteoarthritis; and Uracyst® and the Uracyst® Test Kit, its patented technology for the diagnosis and treatment of interstitial cystitis (IC), an inflammatory disease of the urinary bladder wall. Stellar also has an in-licensing agreement for NMP22® BladderChek®, a proteomics-based diagnostic test for the diagnosis and monitoring of bladder cancer. |
|||||
For more information on Stellar Pharmaceuticals visit the web site at www.stellarpharma.com.
 |
|||||
